Extensive-stage Small Cell Lung Cancer - Gallipoli Medical Research
BMS-986489 in combination with Carboplatin and Etoposide is being compared to Atezolizumab plus Carboplatin and Etoposide as first‑line therapy for extensive‑stage small cell lung cancer.
Bizonyítékszint: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Kapcsolódó jelek
- EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy
- Treatment of Small‑Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline
- Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
- Cancer's protective shield: Blocking a signaling pathway could make small cell lung tumors visible to T cells
- Radiogenomics of clear‑cell renal cell carcinoma: Associations between CT imaging features and mutations